SARS-CoV-2 infects cells via its spike protein binding to its surface receptor on target cells
and results in acute symptoms involving especially the lungs known as COVID-19. However …

COVID‐19 leads to severe respiratory problems, but also to long‐COVID syndrome
associated primarily with cognitive dysfunction and fatigue. Long‐COVID syndrome …

The COVID-19 pandemic necessitated the rapid production of vaccines aimed at the
production of neutralizing antibodies against the COVID-19 spike protein required for the …

The number of patients suffering from long-COVID is currently increasing rapidly, even after
the acute symptoms of COVID-19 have improved. The objective of this study was to …

Background Neurological COVID-19 disease has been reported widely, but published
studies often lack information on neurological outcomes and prognostic risk factors. We …

SARS-CoV-2 infects cells via its spike (S) protein binding to its surface receptor angiotensin
converting enzyme 2 (ACE2) on target cells and results in acute symptoms involving …

Mast cells (MC) are ubiquitous in the body and are critical for allergic diseases, but also in
immunity and inflammation, as well as potential involvement in the pathophysiology of …

Objective Central nervous system involvement in coronavirus disease 2019 (COVID-19) has
been increasingly reported. We performed a systematic review and meta-analysis to …

The prevalence of autism spectrum disorder (ASD) continues to increase, but no distinct
pathogenesis or effective treatment are known yet. The presence of many comorbidities …

Since the pandemic of the coronavirus disease 2019 (COVID-19) infection, many people
have been affected in different ways. The majority of infected people experience mild to …